{"disease":{"id":"pnh-paroxysmal-nocturnal-hemoglobinuria","name":"pnh paroxysmal nocturnal hemoglobinuria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07212426","title":"Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Longbio Pharma","has_results":false},{"nct_id":"NCT07256301","title":"A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Shanghai Lanyi Therapeutics Co., Ltd.","has_results":false},{"nct_id":"NCT06978699","title":"A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"S-INFINITY Pharmaceuticals Co., Ltd","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}